Dai et al. [8] postulated that intratumor CXCL13+ CD8+ T cell infiltration compromised the function of CD8+ T cells, rendering ccRCC patients with poor clinical outcome. This evidence concerns the gene CD8A and nonpapillary renal cell carcinoma.